1. J Hepatol. 2011 Sep;55(3):730-731. doi: 10.1016/j.jhep.2011.01.024. Epub 2011 
Feb 12.

SLC40A1-R178G mutation and ferroportin disease.

Speletas M(1), Onoufriadis E(2), Kioumi A(3), Germenis AE(2).

Author information:
(1)Department of Immunology and Histocompatibility, University of Thessaly, 
Medical School, 41110 Biopolis, Larissa, Greece. Electronic address: 
maspel@med.uth.gr.
(2)Department of Immunology and Histocompatibility, University of Thessaly, 
Medical School, Larissa, Greece.
(3)Hematology Department, Papageorgiou General Hospital, Thessaloniki, Greece.

Comment in
    J Hepatol. 2013 Aug;59(2):397. doi: 10.1016/j.jhep.2013.03.005.
    J Hepatol. 2013 Aug;59(2):396-7. doi: 10.1016/j.jhep.2013.03.006.

Comment on
    J Hepatol. 2010 Nov;53(5):941-9. doi: 10.1016/j.jhep.2010.05.016.

DOI: 10.1016/j.jhep.2011.01.024
PMID: 21320560 [Indexed for MEDLINE]